7-fluoro-4-(4-(2-(1H-imidazol-1-yl)ethyl)piperazin-1-yl)-pyrrolo[1,2-a]quinoxaline

ID: ALA576046

PubChem CID: 44542078

Max Phase: Preclinical

Molecular Formula: C20H21FN6

Molecular Weight: 364.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Fc1ccc2c(c1)nc(N1CCN(CCn3ccnc3)CC1)c1cccn12

Standard InChI:  InChI=1S/C20H21FN6/c21-16-3-4-18-17(14-16)23-20(19-2-1-6-27(18)19)26-12-10-24(11-13-26)8-9-25-7-5-22-15-25/h1-7,14-15H,8-13H2

Standard InChI Key:  ASQVLAWCAVGHRV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
    1.8518  -17.5575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8676  -18.3782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6550  -18.6200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1282  -17.9458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6332  -17.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5773  -13.8524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5784  -14.6784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8648  -15.0906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8666  -13.4403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1524  -13.8487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1490  -14.6805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4309  -15.0911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7117  -14.6746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4378  -13.4276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7147  -13.8448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0944  -13.2859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4343  -12.5234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2645  -12.6110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9975  -15.0847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9985  -15.9129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2882  -16.3229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4265  -15.9128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4265  -15.0882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2882  -14.6736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1392  -16.3256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2921  -15.0897    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.1381  -17.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  2  0
 13 15  1  0
 14 15  1  0
  6  7  2  0
  2  3  2  0
  7  8  1  0
  8 11  2  0
  3  4  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 10  9  2  0
 13 19  1  0
 19 20  1  0
  9  6  1  0
 10 11  1  0
  4  5  2  0
  5  1  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
  1  2  1  0
 22 25  1  0
 10 14  1  0
  7 26  1  0
 11 12  1  0
 25 27  1  0
 27  1  1  0
M  END

Associated Targets(non-human)

Htr3a Serotonin 3a (5-HT3a) receptor (173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 364.43Molecular Weight (Monoisotopic): 364.1812AlogP: 2.65#Rotatable Bonds: 4
Polar Surface Area: 41.60Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.76CX LogP: 2.40CX LogD: 1.88
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -2.08

References

1. Butini S, Budriesi R, Hamon M, Morelli E, Gemma S, Brindisi M, Borrelli G, Novellino E, Fiorini I, Ioan P, Chiarini A, Cagnotto A, Mennini T, Fracasso C, Caccia S, Campiani G..  (2009)  Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization.,  52  (21): [PMID:19831400] [10.1021/jm901126m]

Source